Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused byCandidaspp. with reduced susceptibility to fluconazole?

Post time 2026-7-23 16:10:48

journal：Journal of Antimicrobial Chemotherapy

Authors：Christelle Boglione-Kerrien; Florian Lemaitre; Elodie Gautier-Veyret; Sarah Baklouti; Anne Hulin; Muriel Cornet; Franoise Botterel; Jeff Morcet; Audrey Le Bot; Marie-Clémence Verdier; Jean-Pierre Gangneux; Hélène Guegan

Published date：2026-7-2

DOI：10.1093/jac/dkag231

PDF link：https://academic.oup.com/jac/art ... 9772183/dkag231.pdf

Article link：https://doi.org/10.1093/jac/dkag231

Article Source：Oxford University Press (OUP)。

Remark：

Post time 2026-7-23 16:10:49

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Oxford] Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused byCandidaspp. with reduced susceptibility to fluconazole?

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Oxford] Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused byCandidaspp. with reduced susceptibility to fluconazole? Copy